Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer

Condition:   HER2-positive Breast Cancer Intervention:   Drug: Pyrotinib+Trastuzumab+Docetaxel+Carboplatin Sponsor:   Shandong University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials